Tempus AI : Tempus AI's CEO Diagnostics Schoenherr Sells 17,314 Shares for $929,990

On August 21, 2026, Thomas Edward Schoenherr, CEO of Diagnostics at Tempus AI, Inc. (TEM), sold 17,314 shares of the company at a price of $61.23 per share, totaling $929,990, according to the SEC Form 4 filing submitted to the Securities and Exchange Commission.

Who is Thomas Edward Schoenherr and What is His Role at Tempus AI?

Thomas Edward Schoenherr serves as the CEO of Diagnostics at Tempus AI, a company specializing in artificial intelligence applied to precision medicine. In this role, he is responsible for the strategy and operations related to diagnostic tests, a critical sector for the company. His position grants him access to sensitive information regarding financial performance, customer contracts, product pipelines, and regulatory developments, making his transactions of interest to investors.

Transaction Details: 17,314 Shares at $61.23 Each

The August 21, 2026 transaction involved the sale of 17,314 ordinary shares of Tempus AI. The per-share price was $61.23, resulting in a total value of $929,990. It is important to distinguish between the per-share price and the total value: the former is the amount paid for each share, while the latter is the total proceeds from the sale. This distinction is crucial for evaluating the relative importance of the transaction for the executive.

Why Insiders Sell Shares – Possible Reasons

Share sales by insiders can stem from various motivations. Portfolio diversification is a common reason: an executive whose compensation is largely tied to shares may seek to reduce concentration in a single stock. Tax planning can also be a factor, particularly for covering tax obligations related to shares acquired through compensation plans. Personal liquidity needs, such as purchasing real estate or funding children's education, may also justify a sale. It is therefore risky to interpret a sale as an unequivocal bearish signal, even though some investors view it as an indicator. In this case, the number of shares sold (17,314) is relatively modest compared to Tempus AI's market capitalization, but it could represent a significant portion of Schoenherr's stake, depending on available information.

How Individual Investors Monitor Form 4 Filings

Insider transactions are made public via the SEC Form 4 filing, which must be submitted within two business days of the transaction. This mandatory filing ensures minimal transparency. Individual investors can access these documents for free on the SEC's EDGAR database by searching for the ticker TEM. Online tools like OpenInsider or financial platforms also provide summaries. However, it is important to note that Form 4 filings only provide a partial glimpse: they do not reveal the exact reasons for the sale, and insiders may have personal motives unrelated to company performance. Additionally, a sale may be pre-planned under a 10b5-1 trading plan, which allows shares to be sold at predetermined times, regardless of knowledge of material non-public information. Investors should therefore incorporate this data into a broader analysis, considering the company's fundamentals and market conditions.